triple-acting 5-HT 2A/5-HT 2C/serotonin transporter inhibitors (Korea Institute of Science and Technology/Korea University)

N/A

Report date: 2025/03/20 09:30:43
NME

Base Information

Drug Nametriple-acting 5-HT 2A/5-HT 2C/serotonin transporter inhibitors (Korea Institute of Science and Technology/Korea University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor antagonistsSerotonin transporter inhibitorsSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2c (5-HT2c) receptorSerotonin transporterSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A